Hydroxy-1-aminoindans and derivatives: Preparation, stability, and reactivity

Journal of Organic Chemistry

Volumn 71, Issue 11, 2006, Pages 4130-4140

  Herzig, Yaacov ^a   Lerman, Lena ^b   Goldenberg, Willy ^a   Lerner, David ^a   Gottlieb, Hugo E ^b   Nudelman, Abraham ^b  

^a TEVA PHARMACEUTICALS   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO MOIETY; HYDROXY-AMINOINDANS; QUINONE METHIDE (QM) INTERMEDIATES; TRICYCLIC ACETALS;

AMINO ACIDS; DERIVATIVES; ETHERS; MOLECULAR ORIENTATION; ORGANIC CHEMICALS; REACTION KINETICS; SALTS;

HYDROCARBONS;

2 ETHOXY 3,3A,4,5 TETRAHYDRO 2H CYCLOPENTA[DE]CHROMENE; 5 HYDROXYAMINOINDAN; 7 HYDROXY 1 AMINOINDAN; 7 HYDROXY 1 PROPARGYLAMINOINDAN; 7 HYDROXYAMINOINDAN; ACETAL DERIVATIVE; AMINE; CHLORIDE; ETHER DERIVATIVE; HYDROXY 1 AMINOINDAN; HYDROXYL GROUP; INDAN DERIVATIVE; QUINONE DERIVATIVE; QUINONE METHIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIELS ALDER REACTION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ISOMER; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

INDANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PRODRUGS;

EID: 33646915422     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo052621m     Document Type: Article

References (56)

1. (a) Youdim, M. B.; Weinstock, M. Mech. Ageing Dev. 2002, 123, 1081-1086.
2. (b) Maruyama, W.; Weinstock, M.; Youdim, M. B.; Nagai, M.; Naoi, M. Neurosci. Lett. 2003, 341, 233-236.
3. Weinstock, M.; Gorodetsky, E.; Gross, A.; Sagi, Y.; Youdim, M. B. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2003, 27, 555-561.
4. Reference 5 and references therein.
5. (a) Oshiro, Y.; Sakurai, Y.; Tanaka, T.; Kikuchi, T.; Hirose, T.; Tottori, K. J. Med. Chem. 1991, 34, 2014-2023.
6. (b) Oshiro, Y.; Sakurai, Y.; Tanaka, T.; Ueda, H.; Kikuchi, T.; Tottori, K. J. Med. Chem. 1991, 34, 2004-2013.
7. (a) Preparation of N-acyltetralinamines and analogues as cholesterol biosynthesis inhibitors. Woitun, E.; Maier, R.; Mueller, P.; Hurnaus, R.; Mark, M.; Eisele, B.; Budzinski, R. M.; Hallermayer, G. Ger. Offen. DE 4438029 A1, 1966.
8. (b) Preparation of N-indanylacetamides and related compounds as cholesterol acyltransferase inhibitors. Clader, J. W.; Fevig, T.; Vaccaro, W.; Berger, J. G. Eur. Pat. Appl. EP 508425 A1, 1992.
9. (c) Bicyclic compounds and their use. Oka, Y.; Nishikawa, K.; Miyake, A. Eur. Pat. Appl. EP 51391 A1, 1982.
10. (d) Synthesis and angiotensin converting enzyme inhibitory activity of N-benzocycloalkylglycine derivatives. Miyake, A.; Itoh, K.; Inada, Y.; Nishikawa, K.; Oka, Y. Takeda Kenkyushoho 1985, 44 (3/4), 171-185.
11. (e) Chromanyl glycines. Oka, Y.; Nishikawa, K.; Miyake, A. US 4521607 A, 1985.
12. Hays, S. J.; Novak, P. M.; Ortwine, D. F.; Bigge, C. F.; Colbry, N. L.; Johnson, C. G.; Lescosky, L. J.; Malone, T. C.; Michael, A.; Reily, M. D.; Coughenour, L. L.; Brahce, L. J.; Shillis, J. L.; Prober, A., Jr. J. Med. Chem. 1993, 36, 654-670.
13. Sterling, J.; Herzig, Y.; Goren, T.; Finkelstein, N.; Lerner, D.; Goldenberg, W.; Miskolczi, I.; Molnar, S.; Rantal, F.; Tamas, T.; Toth, G.; Zagyva, A.; Zekany, A.; Lavian, G.; Gross, A.; Friedman, R.; Razin, M.; Huang, W.; Krais, B.; Chorev, M.; Youdim, M. B.; Weinstock, M. J. Med. Chem. 2002, 45, 5260-5279.
14. (a) Talley, J. J. J. Org. Chem. 1985, 50, 1695-1699.
15. (b) Arduini, A.; Bosi, A.; Pochini, A.; Ungaro, R. Tetrahedron 1985, 41, 3095-3103.
16. (c) Letulle, M.; Guenot, P.; Ripoll, J. L. Tetrahedron Lett. 1991, 32, 2013-2016.
17. (d) Yato, M.; Ohwada, T.; Shudo, K. J. Am. Chem. Soc. 1990, 112, 5341-5342.
18. Hogeveen, H.; Heldeweg, R. F. J. Am. Chem. Soc. 1976, 98, 6040-6042.
19. Eck, V.; Schweig, A.; Vermeer, H. Tetrahedron Lett. 1978, 27, 2433-2436.
20. (a) Katada, T.; Eguchi, S.; Esaki, T.; Sasaki, T. J. Chem. Soc., Perkin Trans. 1 1984, 11, 2649-2653.
21. (b) Katritzky, A. R.; Lan, X. Synthesis 1992, 761-764.
22. (c) Nakatani, K.; Higashida, N.; Saito, I. Tetrahedron Lett. 1997, 38, 5005-5008.
23. (a) Breuer, E.; Melumad, D. Tetrahedron Lett. 1969, 23, 3595-3596.
24. (b) Gardner, P. D.; Rafsanjani, H. S.; Rand, L. J. Am. Chem. Soc. 1959, 81, 3364-3367.
25. Landsiedel-Maier, D.; Frahm, A. W. Arch. Pharm. (Weinheim, Ger.) 1998, 331, 59-71.
26. (a) Kraus, M.; Bazant, V. Collect. Czech. Chem. Commun. 1963, 28, 1877-1884.
27. (b) Matlin, A. R.; Inglin, T. A.; Berson, J. A. J. Am. Chem. Soc. 1982, 104, 4954-4955.
28. Breslow, R.; McClure, D. E. J. Am. Chem. Soc. 1976, 98, 258-259.
29. Musso, H. Chem. Ber. 1971, 104, 1017-1024.
30. Awwal, A.; Hibbert, F. J. Chem. Soc., Perkin Trans. 2 1977, 1, 152-156.
31. Borne, R. F.; Forrester, M. L.; Waters, I. W. J. Med. Chem. 1977, 20, 771-776.
32. Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors. Blaugrund, E.; Herzig, Y.; Sterling, J. PCT Int Appl 2003072055, Sept. 4, 2003.
33. (a) 1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof. Lunsford, C. D.; Chen, Y. H. US Patent 4,379,167, 1983.
34. (b) Scharden, G. J. Anal. Appl. Pyrolysis 1979, 1, 159-64.
35. (a) Michel, S.; Desbene, S.; Gesson, J. P.; Monneret, C.; Tillequin, F. Stud. Nat. Prod. Chem. 2000, 21, 157-180.
36. (b) Leenders, R. G. G.; Gerrits, K. A. A.; Ruijtenbeek, R.; Scheeren, H. W.; Haisma, H. J.; Boven, E. Tetrahedron Lett. 1995, 36, 1701-1704.
37. (c) Leenders, R. G. G.; Damen, E. W. P.; Bijsterveld, E. J. A.; Scheeren, H. W.; Houba, P. H. J.; Van der Meulen-Muileman, I. H.; Boven, E.; Haisma, H. J. Bioorg. Med. Chem. 1999, 7, 1597-1610.
38. Chakraborti, A. K.; Sharma, L.; Nayak, M. K. J. Org. Chem. 2002, 67, 6406-6414.
39. Hall, H. K., Jr.; Rasoul, H. A. A.; Gillard, M.; Abdelkader, M.; Nogues, P.; Sentman, R. C. Tetrahedron Lett. 1982, 23, 603-606.
40. Goldschmidt, Z.; Levinger, S.; Gottlieb, H. E. Tetrahedron Lett. 1994, 35, 7273-7276.
41. Descotes, G.; Martin, J. C.; Mathicolonis, N. Bull. Soc. Chim. Fr. 1972, 1077-1084.
42. Fischer, M.; Shi, Y.; Zhao, B.; Snieckus, V.; Wan, P. Can. J. Chem. 1999, 77, 868-874.
43. (a) Noureldin, N. A.; Zhao, D.; Lee, D. O. J. Org. Chem. 1997, 62, 8767-72.
44. (b) Ohkata, K.; Akiyama, M.; Wada, K.; Sakaue, S.; Toda, Y.; Hanafusa, T. J. Org. Chem. 1984, 49, 2517-2520.
45. Miyake, A.; Itoh, K.; Tada, N.; Tanabe, M.; Hirata, M.; Oka, Y. Chem. Pharm. Bull. 1983, 31, 2329-2348.
46. (a) Garnier, S. V.; Larock, R. C. J. Am. Chem. Soc. 2003, 125, 4804-4807.
47. (b) Haadsma-Svensson, S. R.; Cleek, K. A.; Dinh, D. M.; Duncan, J. N.; Haber, C. L.; Huff, R. M.; Lajiness, M. E.; Nichols, N. F.; Smith, M. W.; Svensson, K. A.; Zaya, M. J.; Carlsson, A.; Lin, C. H. J. Med. Chem. 2001, 44, 4716-4732.
48. Gazit, A.; Osherov, N.; Posner, I.; Yaish, P.; Poraduso, E.; Gilon, C.; Levitzki, A. J. Med. Chem. 1991, 34, 1896-1907.
49. Panetta, C. A.; Bunce, S. C. J. Org. Chem. 1961, 26, 4859-4866.
50. Chromanyl Glycines, Oka, Y.; Nishikawa, K.; Miyake, A. US Patent 4,521,607, June 4, 1985.
51. (a) Sakata, K.; Tachifuji, Y.; Hashimoto, M. Synth. React. Inorg. Met.-Org. Chem. 1990, 20, 901-908.
52. (b) Kanatomi, H.; Murase, I. Bull. Chem. Soc. Jpn. 1970, 43, 226-231.
53. Calvo, K. C. J. Org. Chem. 1987, 52, 3654-358.
54. Searcey, M.; Grewal, S. S.; Madeo, F.; Tsoungas, P. G. Tetrahedron Lett. 2003, 44, 6745-6747.
55. Lau, C. K.; Williams, H. W. R.; Tardiff, S.; Dufresne, C.; Scheigetz, J.; Belanger, P. C. Can. J. Chem. 1989, 67, 1384-1387.
56. Tsutomu, I.; Seiichi, I.; Kikumasa, S. Bull Chem. Soc. Jpn. 1990, 63, 1062-1068.